Of the many proposed driver mutations, TERT promoter mutations have recently been under intense interest, owing to their high proportional representation in HCC (54–60%) and their unique role in oncogenesis [26,27,40,41,42]. This evidence concerns the gene TERT and hepatocellular carcinoma.